KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Equity Ratio (2016 - 2025)

Historic Equity Ratio for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 0.02.

  • AbbVie's Equity Ratio fell 14661.38% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 14661.38%. This contributed to the annual value of 0.02 for FY2024, which is 6775.22% down from last year.
  • As of Q3 2025, AbbVie's Equity Ratio stood at 0.02, which was down 14661.38% from 0.0 recorded in Q2 2025.
  • AbbVie's Equity Ratio's 5-year high stood at 0.12 during Q4 2022, with a 5-year trough of 0.02 in Q3 2025.
  • In the last 5 years, AbbVie's Equity Ratio had a median value of 0.09 in 2023 and averaged 0.07.
  • As far as peak fluctuations go, AbbVie's Equity Ratio surged by 21222.9% in 2021, and later plummeted by 14661.38% in 2025.
  • Over the past 5 years, AbbVie's Equity Ratio (Quarter) stood at 0.11 in 2021, then rose by 18.22% to 0.12 in 2022, then crashed by 38.03% to 0.08 in 2023, then tumbled by 67.75% to 0.02 in 2024, then crashed by 179.28% to 0.02 in 2025.
  • Its Equity Ratio stands at 0.02 for Q3 2025, versus 0.0 for Q2 2025 and 0.01 for Q1 2025.